Effect of integrin α7 on cell proliferation, invasion, apoptosis and the PI3K/AKT pathway, and its association with clinicopathological features in endometrial cancer

Liang,Minglin; Liu,Cong; Lei,Tao; Guo,Shiyi; Min,Jie

doi:10.3892/ol.2022.13612

Effect of integrin α7 on cell proliferation, invasion, apoptosis and the PI3K/AKT pathway, and its association with clinicopathological features in endometrial cancer

Authors:
- Minglin Liang
- Cong Liu
- Tao Lei
- Shiyi Guo
- Jie Min
View Affiliations

Affiliations: Department of Gynecology and Obstetrics, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei 430022, P.R. China
Published online on: November 23, 2022 https://doi.org/10.3892/ol.2022.13612
Article Number: 26
Copyright: © Liang et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Targeting integrin α7 (ITGA7) suppresses malignant progression of several types of cancer, including tongue squamous cell carcinoma, hepatocellular carcinoma and non‑small cell lung cancer, while the effect of its knockdown on cell function and its association with clinicopathological features in endometrial cancer (EC) is unclear. The present study aimed to investigate this issue. ITGA7 was knocked down by short‑interfering (si)RNA in Ishikawa and RL95‑2 cells followed by western blotting and reverse transcription‑quantitative PCR assays. Subsequently, cell proliferation, apoptosis, invasion and expression levels of PI3K, phosphorylated (p‑) PI3K, AKT and p‑AKT were determined using Cell Counting Kit‑8, TUNEL, Transwell assays and western blotting. Moreover, ITGA7 in tumor and adjacent tissues from 50 patients with endometrial cancer was detected using immunohistochemical assay. ITGA7 expression was increased in EC cell lines (HEC‑1A, RL95‑2, Ishikawa and KLE) compared with telomerase‑immortalized human endometrial stromal cells (THESCs). In both Ishikawa and RL95‑2 cells, three ITGA7 siRNAs all demonstrated good efficiency on ITGA7 knockdown, amongst which the one with the highest efficiency was selected for the following experiments. ITGA7 knockdown reduced cell proliferation and invasion, while inducing apoptosis; moreover, it suppressed p‑PI3K/PI3K and p‑AKT/AKT ratios. In patients with EC, ITGA7 expression was increased in tumor tissues compared with adjacent tissues, and its lower tumor expression was associated with myometrial invasion (<1/2), non‑lymphovascular invasion and decreased FIGO stage. In conclusion, ITGA7 knockdown repressed proliferation, invasion and the PI3K/AKT pathway while inducing apoptosis in EC cell lines, and its insufficiency was associated with less advanced tumor features in EC patients. These results indicated that ITGA7 may be a potential target for the treatment of EC.

View Figures

View References

1	Lu KH and Broaddus RR: Endometrial cancer. N Engl J Med. 383:2053–2064. 2020. View Article : Google Scholar : PubMed/NCBI
2	Paleari L, Pesce S, Rutigliani M, Greppi M, Obino V, Gorlero F, Vellone VG and Marcenaro E: New insights into endometrial cancer. Cancers (Basel). 13:14962021. View Article : Google Scholar : PubMed/NCBI
3	Saleh M, Virarkar M, Bhosale P, El Sherif S, Javadi S and Faria SC: Endometrial cancer, the current international federation of gynecology and obstetrics staging system, and the role of imaging. J Comput Assist Tomogr. 44:714–729. 2020. View Article : Google Scholar : PubMed/NCBI
4	Javadian P and Nezhat F: Endometrial carcinoma and its precursors. Adv Exp Med Biol. 1242:59–72. 2020. View Article : Google Scholar
5	Friedenreich CM, Ryder-Burbidge C and McNeil J: Physical activity, obesity and sedentary behavior in cancer etiology: Epidemiologic evidence and biologic mechanisms. Mol Oncol. 15:790–800. 2021. View Article : Google Scholar
6	Ryan NA, McMahon RF, Ramchander NC, Seif MW, Evans DG and Crosbie EJ: Lynch syndrome for the gynaecologist. Obstet Gynaecol. 23:9–20. 2021. View Article : Google Scholar
7	Kyo S and Nakayama K: Endometrial cancer as a metabolic disease with dysregulated PI3K signaling: Shedding light on novel therapeutic strategies. Int J Mol Sci. 21:60732020. View Article : Google Scholar
8	McMellen A, Woodruff ER, Corr BR, Bitler BG and Moroney MR: Wnt Signaling in gynecologic malignancies. Int J Mol Sci. 21:42722020. View Article : Google Scholar
9	Gómez-Raposo C, Merino Salvador M, Aguayo Zamora C, Garcia de Santiago B and Casado Sáenz E: Immune checkpoint inhibitors in endometrial cancer. Crit Rev Oncol Hematol. 161:1033062021. View Article : Google Scholar
10	Concin N, Creutzberg CL, Vergote I, Cibula D, Mirza MR, Marnitz S, Ledermann JA, Bosse T, Chargari C, Fagotti A, et al: ESGO/ESTRO/ESP guidelines for the management of patients with endometrial carcinoma. Virchows Arch. 478:153–190. 2021. View Article : Google Scholar : PubMed/NCBI
11	Cooper J and Giancotti FG: Integrin signaling in cancer: Mechanotransduction, stemness, epithelial plasticity, and therapeutic resistance. Cancer Cell. 35:347–367. 2019. View Article : Google Scholar
12	Park HJ, Park JE, Lee H, Kim SJ, Yun JI, Kim M, Park KH and Lee ST: Integrins functioning in uterine endometrial stromal and epithelial cells in estrus. Reproduction. 153:351–360. 2017. View Article : Google Scholar : PubMed/NCBI
13	Lv Z, Yang Y and Yang C: Integrin α7 correlates with worse clinical features and prognosis, and its knockdown inhibits cell proliferation and stemness in tongue squamous cell carcinoma. Int J Oncol. 56:69–84. 2020.
14	Ge JC, Wang YX, Chen ZB and Chen DF: Integrin alpha 7 correlates with poor clinical outcomes, and it regulates cell proliferation, apoptosis and stemness via PTK2-PI3K-Akt signaling pathway in hepatocellular carcinoma. Cell Signal. 66:1094652020. View Article : Google Scholar
15	Xia D, Chen B and Yang X: Correlation of integrin alpha 7 with clinicopathological characteristics and survival profiles, as well as its regulatory role in cell proliferation, apoptosis, and stemness in non-small-cell lung cancer. J Clin Lab Anal. 33:e229732019. View Article : Google Scholar
16	Zhu T, Chen R, Wang J, Yue H, Lu X and Li J: The prognostic value of ITGA and ITGB superfamily members in patients with high grade serous ovarian cancer. Cancer Cell Int. 20:2572020. View Article : Google Scholar
17	Livak KJ and Schmittgen TD: Analysis of relative gene expression data using real-time quantitative PCR and the 2(−Delta Delta C(T)) method. Methods. 25:402–408. 2001. View Article : Google Scholar : PubMed/NCBI
18	Li X, Wang J, Zhang C, Lin C, Zhang J, Zhang W, Zhang W, Lu Y, Zheng L and Li X: Circular RNA circITGA7 inhibits colorectal cancer growth and metastasis by modulating the Ras pathway and upregulating transcription of its host gene ITGA7. J Pathol. 246:166–179. 2018. View Article : Google Scholar
19	Tian T, Lai X, Xiang K, Han X, Yin S, Cabrera RM, Steele JW, Lei Y, Cao X, Finnell RH, et al: Hypermethylation of PI3K-AKT signalling pathway genes is associated with human neural tube defects. Epigenetics. 17:133–146. 2022. View Article : Google Scholar : PubMed/NCBI
20	Liao HD, Mao Y and Ying YG: The involvement of the laminin-integrin α7β1 signaling pathway in mechanical ventilation-induced pulmonary fibrosis. J Thorac Dis. 9:3961–3972. 2017. View Article : Google Scholar : PubMed/NCBI
21	Wu Z, Kong X and Wang Z: Integrin α7 knockdown suppresses cell proliferation, migration, invasion and EMT in hepatocellular carcinoma. Exp Ther Med. 21:3092021. View Article : Google Scholar : PubMed/NCBI
22	Shi X, Wang J, Lei Y, Cong C, Tan D and Zhou X: Research progress on the PI3K/AKT signaling pathway in gynecological cancer (review). Mol Med Rep. 19:4529–4535. 2019.PubMed/NCBI
23	du Rusquec P, Blonz C, Frenel JS and Campone M: Targeting the PI3K/Akt/mTOR pathway in estrogen-receptor positive HER2 negative advanced breast cancer. Ther Adv Med Oncol. 12:17588359209409392020. View Article : Google Scholar
24	Cancer Genome Atlas Research Network, . Kandoth C, Schultz N, Cherniack AD, Akbani R, Liu Y, Shen H, Robertson AG, Pashtan I, Shen R, et al: Integrated genomic characterization of endometrial carcinoma. Nature. 497:67–73. 2013. View Article : Google Scholar : PubMed/NCBI
25	Liu H, Zhang L, Zhang X and Cui Z: PI3K/AKT/mTOR pathway promotes progestin resistance in endometrial cancer cells by inhibition of autophagy. Onco Targets Ther. 10:2865–2871. 2017. View Article : Google Scholar : PubMed/NCBI
26	Ni M, Zhao Y and Wang X: Suppression of synuclein gamma inhibits the movability of endometrial carcinoma cells by PI3K/AKT/ERK signaling pathway. Genes Genomics. 43:633–641. 2021. View Article : Google Scholar : PubMed/NCBI